Financial Consulate’s Aura Biosciences AURA Stock Holding History

Financial Consulate’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.44K	Buy	+230	New	+$1.64K	﹤0.01%	1207

Other funds holding AURA

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Financial Consulate's AURA Position: Q3 2026 in Review

Financial Consulate opened a new position in Aura Biosciences (AURA) in Q3 2026: 230 shares worth $1.44K. The stake represents ﹤0.01% of the portfolio and ranks #1207 among its holdings.

18 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

Financial Consulate held 230 shares of Aura Biosciences worth $1.44K as of Q3 2026.
Aura Biosciences was a new Financial Consulate position in Q3 2026.
Aura Biosciences made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1207 holding.
18 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.